Legacy MEDSearch

JANUARY 18, 2023

Food and Drug Administration (FDA) 510(k) clearance to aid in the early detection of sepsis for the approximately 30 million adult patients with signs and symptoms of infection who present to US emergency departments (ED) each year. 1 The risk of death from sepsis increases by as much as 8 percent each hour the condition goes untreated.

Food and Drug Administration 98

Food and Drug Administration FDA Recruitment Physicians 98

Healthcare Success

MAY 9, 2022

We know that today’s healthcare consumers want instant and accessible services. . The QR code allows hospitals and healthcare providers to satisfy this need with immediate physician-patient interaction and engagement – all through smartphones and tablets. . Patient verification. Patient marketing. Patient payment.

Leads 112

Leads Patients Healthcare Provider Healthcare 112

Clarify Health

MAY 23, 2023

Klinger is a healthcare and technology investor and board director with 20 years of experience, including board governance and general management of venture capital-backed, private equity-backed, and public growth companies in the healthcare, financial services, internet, enterprise software, and retail sectors. healthcare.”

Retail 52

Retail Healthcare Healthcare Management 52

PM360

SEPTEMBER 15, 2022

The term “patient centricity” has been around for over a decade, and since its first utterance the buzzword has been praised, dissected, criticized, and everything in between. The concept has always been worthwhile, but people within and outside of the industry have wondered whether the industry was truly becoming more patient centric?

Patients 98

Patients Healthcare Healthcare Marketing 98

Legacy MEDSearch

OCTOBER 19, 2023

ACES focuses on patient-centered outcomes, potentially eliminating the need for a long hospital stay and chronic drainage at home. Chief, Pulmonary and Critical Care Medicine Dartmouth-Hitchcock Medical Center. This is a potentially perfect solution,” said David Feller-Kopman, M.D., Added Kevin Henseler, M.D.,

FDA 52

FDA Food and Drug Administration Recruitment Medical 52

Legacy MEDSearch

DECEMBER 1, 2022

HemoSonics, LLC , a leading medical device company delivering individualized diagnostic solutions for Patient Blood Management (PBM), announced that it has received 510(k) market clearance from the U.S. “Point-of-care data is the answer to PBM-guided patient decisions. market today.

FDA 95

FDA Food and Drug Administration Recruitment Medical 95

Legacy MEDSearch

AUGUST 22, 2023

Levita Magnetics, whose mission is to help more patients get access to better surgery, announced today it has received U.S. “Today marks a significant milestone in Levita’s mission to provide more patients access to state-of-the-art surgical technology. Food and Drug Administration (FDA) clearance for its MARS platform.

FDA 52

FDA Food and Drug Administration Recruitment Medical 52

Legacy MEDSearch

DECEMBER 6, 2022

With ActivSight, surgeons can access critical intraoperative visual data as augmented reality overlays, helping to increase surgical outcomes and patient safety. “As We believe ActivSight will be a game-changer in the operating room by revolutionizing surgical vision and, ultimately, improving surgical care and patient safety.

Food and Drug Administration 98

Food and Drug Administration Safety Recruitment Medical 98

Nixon Gwilt Law

JULY 14, 2023

The Centers for Medicare & Medicaid Services (“CMS”) released its much-anticipated Proposed Medicare Physician Fee Schedule for CY 2024 (the “Proposed Rule”) on July 13, 2023. However, patients who first received remote monitoring services during the PHE when this requirement was waived are now considered “established patients.”

Physicians 40

Physicians Management Patients Education 40

Legacy MEDSearch

AUGUST 29, 2023

The distribution agreement will provide patients in the Department of Veterans Affairs (VA) and Department of Defense (DoD) access to the SmartShot® Marrow Access Device, a novel solution for using the body’s own stem cells and healing capabilities to treat orthopedic soft tissue injuries of the knee, hip, shoulder, foot, and ankle.

Medical 52

Medical Distribution Recruitment Government 52

Legacy MEDSearch

SEPTEMBER 18, 2023

Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) supplement to permit the expansion of the study of the eShunt System in patients with Normal Pressure Hydrocephalus (NPH) to additional study participants and clinical sites. CereVasc, Inc., Carl Heilman, M.D., and Adel Malek, M.D., Carl Heilman, M.D.,

Food and Drug Administration 52

Food and Drug Administration FDA Patients Recruitment 52

Legacy MEDSearch

OCTOBER 3, 2023

The Seraph 100 is a patented blood filter containing a biomimetic surface, similar to that found in the human circulatory system that removes pathogens that could otherwise overwhelm a patient; a common source of severe/critical illness. RAC & Chief Regulatory Officer for ExThera. “I

FDA 52

FDA Food and Drug Administration Recruitment Medical 52

PM360

DECEMBER 14, 2023

From developing ground-breaking new medicines to implementing better ways to ensure patients can access and stay on therapy to experimenting with new technology that changes how care is delivered—innovation is at the heart of everything this industry does.

Insurance 64

Insurance Marketing Healthcare Healthcare 64

Legacy MEDSearch

APRIL 19, 2023

Because NCCT imaging is readily available and is the initial imaging modality used for stroke and trauma patients, care teams can make time-sensitive workflow and transfer decisions faster. RapidAI – where AI meets patient care.

FDA 52

FDA Recruitment Medical Patients 52

Legacy MEDSearch

OCTOBER 4, 2023

Stimdia Medical, a medical device company developing innovative technologies to improve respiratory care, today announced the initiation of its FDA approved pivotal trial to investigate the impact of phrenic nerve stimulation (PNS) on the time to liberate patients from mechanical ventilation.

Medical 52

Medical Patients FDA Recruitment 52

Legacy MEDSearch

AUGUST 29, 2022

Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) application to initiate a pilot trial of the eShunt ® System in patients who develop communicating hydrocephalus post aneurysmal subarachnoid hemorrhage (paSAH). . Details on the trial will soon be posted to www.clinicaltrials.gov. About CereVasc, Inc.

FDA 52

FDA Food and Drug Administration Recruitment Physicians 52

Legacy MEDSearch

NOVEMBER 6, 2023

HistoSonics, ( www.histosonics.com ), the manufacturer of the non-invasive Edison® Histotripsy System and novel sonic beam therapy, announced today that the Centers of Medicare & Medicaid Services (CMS) set a new payment rate for histotripsy of liver tumors procedures, increasing the payment rate to $17,500.

Recruitment 52

Recruitment Physicians Medical Patients 52

Legacy MEDSearch

FEBRUARY 28, 2023

RADIANCE II is a randomized, sham-controlled US FDA IDE pivotal trial of the Paradise uRDN System in the treatment of patients with uncontrolled hypertension. Conducted as an international multicenter study at more than 60 study centers in eight countries, 224 patients with uncontrolled hypertension were randomized 2:1 to uRDN or a sham.

Networking 98

Networking Medical Physicians Safety 98

Legacy MEDSearch

OCTOBER 31, 2023

The simple instrumentation allows surgeons with varying levels of experience with unicondylar knee arthroplasty to achieve efficient and consistent surgical outcomes,” said Dr. Cass Nakasone, an orthopedic surgeon at Straub Medical Center in Honolulu, HI. Contact us to discuss partnering with Legacy MedSearch on your position.

Recruitment 52

Recruitment Distribution Manufacturing Engineering 52

Legacy MEDSearch

JULY 27, 2023

The UltraSight real-time AI guidance software can assist medical professionals without sonography experience in acquiring cardiac ultrasound images at the point of care in multiple settings, allowing for more widespread detection of heart disease and providing patients easier access to cardiac monitoring.

FDA 52

FDA Recruitment Medical Patients 52

Legacy MEDSearch

AUGUST 16, 2023

Centers for Medicare and Medicaid Services (CMS) granted New Technology Add-on Payment (NTAP) for ClarityPro of up to $913.90 per eligible Medicare patient case. ClarityPro is now the only FDA-indicated device for the diagnosis of ESE in adult patients over the age of 18. NTAP reimbursement of up to $913.90

FDA 52

FDA Food and Drug Administration Healthcare Provider Recruitment 52

Legacy MEDSearch

AUGUST 25, 2023

The BAROguard System combines Paragonix’s existing advanced hypothermic preservation technology with automated continuous and active airway pressure control, ensuring that an optimal temperature range and a clinically recommended inflation pressure range for donor lungs are maintained throughout the journey from donor to recipient patient.

FDA 52

FDA Food and Drug Administration Transportation Recruitment 52

Legacy MEDSearch

SEPTEMBER 12, 2023

The LimFlow System for Transcatheter Arterialization of Deep Veins (TADV) is designed to reestablish blood flow in deep veins for “no-option” CLTI patients. The therapy is designed to save patients’ legs from major amputation, as limb loss is associated with significant complications, mortality, and deterioration of quality of life.

FDA 52

FDA Patients Food and Drug Administration Recruitment 52

Legacy MEDSearch

MAY 12, 2023

This cutting-edge technology enables surgeons to transform a patient’s imaging data into a 3D hologram, which can be projected onto the patient’s body with extreme precision. It also provides integrated 2D and 3D immersive navigation views and ongoing hologram-to-patient registration. Visit Novarad at novarad.net.

FDA 52

FDA Recruitment Medical Management 52

Legacy MEDSearch

APRIL 13, 2023

a privately held medical device company developing minimally invasive therapies to directly treat the dilated left ventricle and reverse the left ventricular remodeling process in patients with congestive heart failure, today announced the completion of $48.5 BioVentrix, Inc., million Series A round financing.

Food and Drug Administration 52

Food and Drug Administration Recruitment Medical Management 52

LEVO Health

OCTOBER 6, 2021

Without a marketing agency, it is extremely difficult to attract new patients or even retain current patients. Studies indicate that over 70% of patients use online reviews to find a new doctor, meaning that a positive online presence is crucial to increasing your patient base. . Manage Your Marketing Budget.

Healthcare 52

Healthcare Healthcare Marketing Medical 52

Legacy MEDSearch

JULY 6, 2023

The InTandem name reflects both the synchronization inherent in the device’s mechanism of action and the partnership formed between patient and device. The burden on patient functioning is also profound. MedRhythms also unveiled the brand name for MR-001: InTandem.

FDA 52

FDA Food and Drug Administration Recruitment Medical 52

Legacy MEDSearch

APRIL 27, 2023

(Innoblative), a private medical device company addressing clinical unmet needs for patients with breast cancer, announced that it received Breakthrough Device Designation from the U.S. The SIRA device is intended for use in breast cancer patients undergoing BCS, commonly referred to as lumpectomy. Are you hiring?

FDA 52

FDA Food and Drug Administration Recruitment Medical 52

Legacy MEDSearch

SEPTEMBER 5, 2023

However, insufficient image guidance precision and treatment control, lead to high risk of recurrence and complications, creating significant barriers to widespread adoption and limiting patients’ eligibility. Legacy MedSearch has more than 35 years of combined experience recruiting in the medical device industry. VisAble.IO

FDA 52

FDA Food and Drug Administration Physicians Recruitment 52

Legacy MEDSearch

SEPTEMBER 20, 2023

a medical imaging company focused on improving the treatment and outcomes for patients with coronary artery disease (CAD), today announced U.S. Intravascular imaging is essential to optimize patient outcomes,“ said Richard A. Francis Hospital and Heart Center. “I SpectraWAVE, Inc., Shlofmitz, M.D.,

Food and Drug Administration 52

Food and Drug Administration Recruitment Physicians Patients 52

Legacy MEDSearch

SEPTEMBER 8, 2023

The study will be initiated in the second half of 2023, enrolling up to 20 patients at up to 5 clinical sites for the first stage of the trial. Legacy MedSearch has more than 35 years of combined experience recruiting in the medical device industry. Contact us to discuss partnering with Legacy MedSearch on your position.

Medical 52

Medical FDA Recruitment Specialization 52

Legacy MEDSearch

DECEMBER 20, 2022

The Premarket Approval (PMA) submission included Module III, with data and analysis of the two-year results from the pivotal Investigational Device Exemption (IDE) clinical trial comparing LimiFlex DST stabilization versus fusion surgery for degenerative spondylolisthesis (degen spondy) patients with spinal stenosis. Empirical Spine, Inc.,

FDA 94

FDA Food and Drug Administration Recruitment Patients 94

Legacy MEDSearch

DECEMBER 7, 2022

The statement continued, “The company had already made steps towards a market introduction in 2021, partnering with the Center for Health Affairs, the Northeast Ohio hospitals association, and its affiliate CHAMPS Group Purchasing, with an aim to provide new surgical tools in the market and operating rooms in Northeast Ohio and the U.S.

Networking 98

Networking Medical Food and Drug Administration Recruitment 98

Legacy MEDSearch

NOVEMBER 2, 2023

Xēnix Medical, a surgical implant company focused on the development of novel science-based solutions for patients requiring spinal fusion surgery, today announced that it has received 510(k) clearance from the U.S. We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search.

Medical 52

Medical FDA Food and Drug Administration Recruitment 52

Legacy MEDSearch

APRIL 13, 2023

This interface provides physicians with an interactive, 360-degree view of the patient’s specific anatomy to allow them to deliver cardiac ablation therapy to patients. We look forward to the potential benefits of CommandEP for our patients.” ” Dr. R. The system is developed by a star team. based in St.

Physicians 52

Physicians Recruitment Medical Patients 52

Legacy MEDSearch

FEBRUARY 14, 2023

“Transcatheter mitral valve replacement is still in its infancy and is becoming an important therapeutic alternative for our patients with severe mitral regurgitation,” said Azeem Latib MD, Director of Interventional Cardiology, Montefiore Medical Center. ” About Tioga Cardiovascular, Inc.

Recruitment 52

Recruitment Management Medical Specialization 52

Healthcare Success

MAY 9, 2022

We know that today's healthcare consumers want instant and accessible services. . The QR code allows hospitals and healthcare providers to satisfy this need with immediate physician-patient interaction and engagement – all through smartphones and tablets. . Patient verification. Patient marketing. Patient payment.

Leads 52

Leads Patients Healthcare Provider Healthcare 52